Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
RPRX
#500
Royalty Pharma plc Class A Ordinary Shares
46.210
0
+2.45%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+2.45%
Variazione Mensile
+13.99%
Variazione di 6 mesi
+24.02%
Variazione Annuale
+24.02%
Chiusura Precedente
45.105
0
Open
46.210
0
Bid
Ask
Low
46.210
0
High
46.210
0
Volume
225
Mercati
Mercato Azionario Statunitense
Salute
RPRX
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
388.13 M
432.96 M
443.17 M
446.69 M
433.32 M
428.42 M
—
Valuation ratios
Enterprise value
303.91 T
242 T
239.29 T
168.93 T
147.08 T
222.94 T
811.84 T
Price to earnings ratio
31.16
39.04
394
11.17
13.36
21.71
70.31
Price to sales ratio
8.85
7.22
7.71
7.24
6.7
9.17
34.98
Price to cash flow ratio
14.93
11.99
8.05
5.7
5.47
8.76
32.76
Price to book ratio
6.31
4.19
3.07
2.61
2.18
3.37
5.6
Enterprise value to EBITDA ratio
168.52 K
113.31 K
577.4 K
109.36 K
120.6 K
150.62 K
509.31 K
Profitability ratios
Return on assets %
0.06
0.04
0
0.07
0.05
0.04
0.04
Return on equity %
0.1
0.06
0
0.11
0.08
0.08
0.08
Return on invested capital %
45.75
39.11
7.99
38.15
30.83
34.06
34.9
Gross margin %
92.64
99.44
50.92
75.24
63.21
86.46
343.51
Operating margin %
75.17
62.49
13.73
63.37
57.1
65.58
262.81
EBITDA margin %
84.97
93.29
18.52
65.6
53.88
62.24
248.14
Net margin %
45.94
27.07
1.91
48.2
37.95
32.42
128.9
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.76
16.81
2.19
7.9
1.44
2.4
8.7
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.13
0.14
0.13
0.14
0.13
0.13
0.13
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.36
0.41
0.36
0.37
0.36
0.44
1.64
Long term debt to total equity ratio
1.21
1.23
1.09
0.94
0.95
1.32
4.75
Per share metrics
Operating cash flow per share
3.35
3.32
4.9
4.96
4.66
4.41
4.4
EBIT per share
2.91
3.45
0.88
2.53
2.02
2.58
2.59
EBITDA per share
2.97
3.52
0.95
2.56
2.05
2.62
2.63
Total debt per share
—
—
—
—
—
—
—
Cash per share
3.4
3.61
3.96
0.82
1.66
1.13
5.89
Net current asset value per share
4.44
4.74
5.83
2.11
3.03
2.71
11.9
Tangible book value per share
12.76
13.91
12.85
10.83
11.69
9.84
40.86
Working capital per share
3.94
4.46
3.17
1.85
0.92
1.58
5.64
Book value per share
7.94
9.51
12.85
10.83
11.69
11.47
45.8
Notizie
TD Cowen alza il target su Royalty Pharma a 50$ per la crescita
TD Cowen raises Royalty Pharma stock price target to $50 on growth
Royalty Pharma raggiunge il massimo di 52 settimane a 46,14 USD
Royalty Pharma stock hits 52-week high at 46.14 USD
Royalty Pharma Stock: 2025 Financial Performance And Strategic Outlook (NASDAQ:RPRX)
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15 - TipRanks.com
Dividend Champion, Contender, And Challenger Highlights: Week Of February 15
BofA Securities conferma il rating Buy sulle azioni di Royalty Pharma con target di $54
Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript
Il titolo AnaptysBio raggiunge il massimo di 52 settimane a $52,56
Azioni Royalty Pharma raggiungono massimo di 52 settimane a 44,94 USD
Royalty Pharma stock hits 52-week high at 44.94 USD